Juan Lin

ORCID: 0000-0003-4202-285X · 3 papers in corpus · active 2021-2026

Study types

  • preprint 1
2026
Risk of endometrial carcinoma in patients with atypical endometrial hyperplasia in a population of predominantly racial and ethnic minorities, a single institution study
Gynecologic oncology ·doi:10.1016/j.ygyno.2026.05.020

OBJECTIVE: To identify clinicopathologic predictors of concurrent endometrial carcinoma (EC) and need for lymph node assessment at time of hysterectomy for atypical endometrial hyperplasia (AEH) in a minority-enriched population. METHODS: …

preprint 2022
Preventing effects of Pen Yan Jing Tablets on sequelae of pelvic inflammatory disease by inhibiting Akt/NF-κB pathway
·doi:10.21203/rs.3.rs-1495843/v1

Abstract Background: Pen Yan Jing tablets (PYJ), a Chinese patent medicine, has been used for sequelae of pelvic inflammatory disease (SPID) effectively. However, the underlying anti-SPID mechanisms of PYJ remain unknown. The Akt/NF-κB path…

2021
Fenton Reaction Facilitates The Fungal Infection On The Unicellular Alga Haematococcus Pluvialis and Discovery of a Biosafe and Environment-Friendly Chemical That Blocks The Infection
·doi:10.21203/rs.3.rs-1147317/v1